Rehabilitation trial using robotic wear curara(R) for patients with cerebrovascular and neurodegenerative diseases. part 2 spinocerebellar degeneration

Rehabilitation trial using robotic wear curara(R) for patients with cerebrovascular and neurodegenerative diseases. part 2 spinocerebellar degeneration - Rehabilitation trial using curara(R) for patients with spinocerebellar degeneration

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034238

Enrollment

Registered

2018-10-02

Start date

2018-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinocerebellar degeneration (SCD)

Interventions

gait training using curara(R) (25-35 min/day, 12 days in total) [day 1-day 6, day 8-day 13]

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with spinocerebellar degeneration (SCD) 2) Age: 20 years <= at entry 3) Able to walk 10 m (even with walking aids such as cane or walker) 4) Able to keep admission in Kakeyu-Misayama Rehabilitation Center, Kakeyu Hospital during the study 5) Berg Balance Scale: 20 <= 6) Written informed consent for the study

Exclusion criteria

Exclusion criteria: 1) Possible causes for gait disturbance other than SCD 2) Not fulfil the body-size criteria for curara(R) model 4 3) Researchers judge the participants inappropriate for the study (for example, severe dementia or psychiatric symptoms, severe spasticity or joint contractures of the legs)

Design outcomes

Primary

Measure	Time frame
10m walking speed (comparison between day 0 and day 14) [day 0, day 7, day 14] [] indicates day of evaluation	—

Secondary

Measure	Time frame
1) 6-min walking distance (comparison between day 0 and day 14) 2) RehaGait(R) measures 3) Berg Balance Scale (BBS) [day 0, day 14] 4) Timed up and go test 5) Scale for the Assessment and Rating of Ataxia (SARA) 6) Outcome measures reported by participants [day 14] 7) Safety sheet (interview to participants) [at least 1 day during 3 days just prior to day 0, and day 0-day 14] Items not specified above by [] are evaluated three times, day 0, day 7, and day 14.	—

Measure

Time frame

1) 6-min walking distance (comparison between day 0 and day 14) 2) RehaGait(R) measures 3) Berg Balance Scale (BBS) [day 0, day 14] 4) Timed up and go test 5) Scale for the Assessment and Rating of Ataxia (SARA) 6) Outcome measures reported by participants [day 14] 7) Safety sheet (interview to participants) [at least 1 day during 3 days just prior to day 0, and day 0-day 14] Items not specified above by [] are evaluated three times, day 0, day 7, and day 14.

—

Countries

Japan

Contacts

Public ContactKunihiro Yoshida

Shinshu University School of Medicine Department of Brain Disease Research

kyoshida@shinshu-u.ac.jp0263-37-3059

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026